1. Home
  2. PRK vs IDYA Comparison

PRK vs IDYA Comparison

Compare PRK & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park National Corporation

PRK

Park National Corporation

HOLD

Current Price

$191.67

Market Cap

3.6B

Sector

Finance

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$39.98

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRK
IDYA
Founded
1908
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.6B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
PRK
IDYA
Price
$191.67
$39.98
Analyst Decision
Hold
Strong Buy
Analyst Count
3
16
Target Price
$184.00
$52.86
AVG Volume (30 Days)
67.5K
701.7K
Earning Date
04-24-2026
05-06-2026
Dividend Yield
2.61%
N/A
EPS Growth
19.21
61.90
EPS
5.64
N/A
Revenue
$664,421,000.00
$218,710,000.00
Revenue This Year
$24.26
N/A
Revenue Next Year
$3.63
$201.05
P/E Ratio
$34.63
N/A
Revenue Growth
2.92
3024.43
52 Week Low
$149.06
$23.23
52 Week High
$215.00
$42.68

Technical Indicators

Market Signals
Indicator
PRK
IDYA
Relative Strength Index (RSI) 36.60 58.13
Support Level $181.01 $33.57
Resistance Level $192.77 $39.93
Average True Range (ATR) 4.14 1.35
MACD -1.97 0.09
Stochastic Oscillator 8.62 59.26

Price Performance

Historical Comparison
PRK
IDYA

About PRK Park National Corporation

Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. The company provides the following principal services: the acceptance of deposits for demand, savings and time accounts; commercial, industrial, consumer and real estate lending, including installment loans, credit cards (which are largely offered through a third party), home equity lines of credit and commercial leasing; trust and wealth management services; cash management; safe deposit operations; electronic funds transfers; and a variety of additional banking-related services.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: